Results 121 to 130 of about 26,503 (228)

Budesonide affects allergic mucociliary dysfunction

, 1998
Airway inflammation characterized by neutrophils and free elastase contributes to allergic mucociliary dysfunction. Glucocorticosteroids are the most important anti-inflammatory agents used in the treatment of asthma, but their effect on allergic ...
Ricardo Otero, Thomas G. O’Riordan, Juan Lopez, Juan R. Sabater, Yongming Mao, William M. Abraham   +5 more
core   +1 more source

Treatment with budesonide/formoterol pressurized metered-dose inhaler in patients with asthma: a focus on patient-reported outcomes

Patient Related Outcome Measures, 2011
Richard D O'ConnorSharp Rees-Stealy Medical Group, San Diego, CA, USAAbstract: In the United States, budesonide/formoterol pressurized metered-dose inhaler (pMDI) is approved for treatment of asthma in patients aged ≥12 years whose asthma ...
Richard D O'Connor
doaj  

Spontaneous Achievers, Responders and Non‐Responders: Aligning Treatment With the Natural History of Bronchopulmonary Dysplasia in Preterm Infants

Acta Paediatrica, Volume 115, Issue 9, Page 1867-1871, September 2026.
ABSTRACT Aim To examine how early pulmonary phenotype influences treatment response and the interpretation of trial outcomes in bronchopulmonary dysplasia (BPD). Methods A narrative review of early respiratory patterns in very preterm infants and their relationship to treatment response, using published trials of postnatal corticosteroids as the ...
Chad C. Andersen, Michael J. Stark
wiley   +1 more source

Effects of budesonide and surfactant in preterm fetal sheep

, 2018
Mechanical ventilation causes lung injury and systemic inflammatory responses in preterm sheep and is associated with bronchopulmonary dysplasia (BPD) in preterm infants. Budesonide added to surfactant decreased BPD by 20% in infants.
Masatoshi Saito, Noah H. Hillman, Kothe, T Brett, Emily Royse, Augusto Schmidt, Hillman, Noah H, Fabrizio Salomone, T. Brett Kothe, Alan H. Jobe, Gabrielle C. Musk, Salomone, Fabrizio, Matthew W. Kemp, Schmidt, Augusto, Watanabe, Shimpei, Musk, Gabrielle C, Royse, Emily, Kemp, Matthew W, Haruo Usuda, Shimpei Watanabe, Saito, Masatoshi, Usuda, Haruo, Jobe, Alan H   +21 more
core   +1 more source

Comparative Real‐World Effectiveness of Anti‐TNF, Ustekinumab and Vedolizumab in Crohn's Disease Over 24 Months: A Pooled Analysis From the Prospective UMBRELLA‐IBD Registry in Germany

Alimentary Pharmacology &Therapeutics, Volume 64, Issue 6, Page 815-827, September 2026.
A pooled analysis from the prospective UMBRELLA‐IBD registry in Germany (n = 1567) showed comparative real‐world effectiveness in treatment persistence and clinical remission of anti‐TNF, Ustekinumab and Vedolizumab in Crohn's disease patients over 24 months.
Arne Bokemeyer, Florian Tran, Sandra Plachta‐Danielzik, Elena Gilman, Thomas Wenske, Matthew Gaskins, Stefan Schreiber, Bernd Bokemeyer   +7 more
wiley   +1 more source

Mucoadhesive Budesonide Solution for the Treatment of Pediatric Eosinophilic Esophagitis

Pharmaceuticals
Eosinophilic Esophagitis is an antigen-mediated inflammatory disease characterized by thickening of the esophageal wall, leading to dysphagia, vomiting, reflux, and abdominal pain. This disease can be treated with a therapeutic approach ranging from diet
Antonio Spennacchio, Antonio Lopalco, Giuseppe Francesco Racaniello, Annalisa Cutrignelli, Flavia Maria la Forgia, Sergio Fontana, Fernanda Cristofori, Ruggiero Francavilla, Angela Assunta Lopedota, Nunzio Denora   +9 more
doaj   +1 more source

Review Article: The Impact of the Gut Microbiome on Ulcerative Colitis Pharmacotherapy

Alimentary Pharmacology &Therapeutics, Volume 64, Issue 6, Page 729-747, September 2026.
The gut microbiome modulates ulcerative colitis pharmacotherapy through microbial drug metabolism, immune regulation and altered drug bioavailability. Microbial composition influences response to aminosalicylates, corticosteroids, immunomodulators, biologics and small molecules, while microbiome‐targeted therapies show emerging promise.
Kate Collins, Srinivas Kamath, Rachel H. Davis, Samuel P. Costello, Robert V. Bryant, Alice S. Day, Paul Joyce   +6 more
wiley   +1 more source

Bronchodilation of formoterol administered with budesonide: Device and formulation effects

, 2008
BACKGROUND: Previous single-dose crossover studies have established therapeutic equivalence of formoterol when administered at the same nominal dose via a dry powder inhaler (DPI) or pressurized hydrofluoroalkane (HFA) metered-dose inhaler (pMDI ...
Mezzanotte, W., Miller, C., Senn, S.
core   +1 more source

Budesonide for ulcerative colitis

, 2006
In this review, we examined studies published on oral and topical formulations of budesonide (Entocort® and Budenofalk®, in Spain: Entocord® and Intestifalk®) for the treatment of ulcerative colitis. This glycocorticosteroid has a potent local action and
Marín-Jiménez,I., Peña,A. S.
core   +1 more source

Contact Sensitisation Trends in Slovenian Children and Adolescents: A Retrospective Single‐Centre Study

Contact Dermatitis, Volume 95, Issue 3, Page 301-308, September 2026.
Nickel sensitisation in children decreased significantly over time, while dyes and isothiazolinones are emerging allergens. These findings underscore shifting exposure patterns and the need for continuous surveillance to guide effective patch testing and prevention strategies.
Mateja Starbek Zorko, Tomaž Lunder, Thomas Peric   +2 more
wiley   +1 more source